In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs. Sun L, Li P, Ju X, Rao J, et al. Cell 2021;184:1865-1883.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun L, Li P, Ju X, Rao J, et al. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs. Cell 2021;184:1865-1883.
PMID: 33636127